Prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal squamous cell carcinoma

Ann Oncol. 2018 Oct 1;29(10):2144-2145. doi: 10.1093/annonc/mdy313.

Authors

H P Sathasivam¹, A Santambrogio², C L Andoniadou², M Robinson¹, S Thavaraj³

Affiliations

¹ Centre for Oral Health Research, Newcastle University, Newcastle upon Tyne, UK.
² Centre for Craniofacial and Regenerative Biology, King's College London, London, UK.
³ Mucosal & Salivary Biology, King's College London, London, UK. Electronic address: [email protected].

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Squamous Cell*
DNA
Humans
Immunohistochemistry
Neoplasm Staging
Netherlands
Oropharyngeal Neoplasms*
Papillomaviridae / genetics*
Papillomavirus Infections*
Prognosis

Substances

DNA

Grants and funding

MR/N005872/1/MRC_/Medical Research Council/United Kingdom